How many institutions held OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share in Q2 2020?

78 institutional investors reported OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share for Q2 2020. Use the holders table for investor-level position and value details.

Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID)

Q: What does CUSIP 690469101 represent in this 13F holders report?

CUSIP 690469101 is the security identifier for OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 690469101

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 134,553,130
Total 13F shares: 21,848,899
Share change: +5,841,631
Total reported value: $161,034,711
Put/Call ratio: 66%
Price per share: $7.37
Number of holders: 78
Value change: +$48,530,099
Number of buys: 56
Number of sells: 35

Quarterly Holders Quick Answers

What is CUSIP 690469101?
CUSIP 690469101 identifies OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 690469101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Consonance Capital Management LP	13F	Company	1.9%	2,580,878	$7,691,000	—	31 Mar 2020	13F
FMR LLC	13F	Company	1.5%	2,084,900	$6,213,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	1.3%	1,698,971	$5,064,000	—	31 Mar 2020	13F
BVF INC/IL	13F	Company	0.96%	1,286,004	$3,832,000	—	31 Mar 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.63%	852,843	$2,541,000	—	31 Mar 2020	13F
CHI Advisors LLC	13F	Company	0.62%	828,413	$2,469,000	—	31 Mar 2020	13F
AXA S.A.	13F	Company	0.61%	816,072	$2,432,000	—	31 Mar 2020	13F
BlackRock Finance, Inc.	13F	Company	0.36%	490,003	$1,461,000	—	31 Mar 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.36%	489,821	$1,460,000	—	31 Mar 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.3%	398,958	$1,189,000	—	31 Mar 2020	13F
PLATINUM INVESTMENT MANAGEMENT LTD	13F	Company	0.28%	382,935	$1,141,000	—	31 Mar 2020	13F
Ikarian Capital, LLC	13F	Company	0.28%	377,737	$1,126,000	—	31 Mar 2020	13F
Tekla Capital Management LLC	13F	Company	0.28%	372,733	$1,111,000	—	31 Mar 2020	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.23%	305,702	$911,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.22%	294,037	$876,000	—	31 Mar 2020	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.18%	242,600	$723,000	—	31 Mar 2020	13F
UBS Group AG	13F	Company	0.15%	207,964	$620,000	—	31 Mar 2020	13F
Informed Momentum Co LLC	13F	Company	0.14%	184,728	$550,000	—	31 Mar 2020	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.12%	158,587	$473,000	—	31 Mar 2020	13F
Fairpointe Capital LLC	13F	Company	0.11%	141,700	$422,000	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.1%	136,251	$406,000	—	31 Mar 2020	13F
MORGAN STANLEY	13F	Company	0.09%	122,061	$364,000	—	31 Mar 2020	13F
Redmile Group, LLC	13F	Company	0.09%	121,950	$363,000	—	31 Mar 2020	13F
Assenagon Asset Management S.A.	13F	Company	0.09%	120,060	$358,000	—	31 Mar 2020	13F
Endurant Capital Management LP	13F	Company	0.09%	116,297	$347,000	—	31 Mar 2020	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.07%	95,738	$285,000	—	31 Mar 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.06%	84,853	$253,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	0.05%	69,849	$209,000	—	31 Mar 2020	13F
BAKER BROS. ADVISORS LP	13F	Company	0.05%	69,471	$207,000	—	31 Mar 2020	13F
BLAIR WILLIAM & CO/IL	13F	Company	0.05%	65,000	$194,000	—	31 Mar 2020	13F
HANTZ FINANCIAL SERVICES, INC.	13F	Company	0.05%	65,000	$194,000	—	31 Mar 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.05%	61,794	$184,000	—	31 Mar 2020	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.04%	58,368	$174,000	—	31 Mar 2020	13F
JANE STREET GROUP, LLC	13F	Company	0.04%	53,461	$160,000	—	31 Mar 2020	13F
ExodusPoint Capital Management, LP	13F	Company	0.04%	50,557	$151,000	—	31 Mar 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.04%	48,190	$144,000	—	31 Mar 2020	13F
ALGERT GLOBAL LLC	13F	Company	0.03%	37,490	$112,000	—	31 Mar 2020	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.02%	31,012	$92,000	—	31 Mar 2020	13F
WEDBUSH SECURITIES INC	13F	Company	0.02%	29,090	$87,000	—	31 Mar 2020	13F
SHUFRO ROSE & CO LLC	13F	Company	0.02%	25,000	$75,000	—	31 Mar 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.02%	23,400	$70,000	—	31 Mar 2020	13F
Qube Research & Technologies Ltd	13F	Company	0.02%	22,442	$67,000	—	31 Mar 2020	13F
Bank of New York Mellon Corp	13F	Company	0.02%	21,463	$64,000	—	31 Mar 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.01%	18,578	$56,000	—	31 Mar 2020	13F
FIRST MANHATTAN CO. LLC.	13F	Company	0.01%	18,000	$53,000	—	31 Mar 2020	13F
COMMONWEALTH EQUITY SERVICES, LLC	13F	Company	0.01%	17,400	$51,000	—	31 Mar 2020	13F
Creative Planning	13F	Company	0.01%	15,532	$46,000	—	31 Mar 2020	13F
CREDIT SUISSE AG/	13F	Company	0.01%	11,671	$35,000	—	31 Mar 2020	13F
Dynamic Technology Lab Private Ltd	13F	Company	0.01%	11,626	$35,000	—	31 Mar 2020	13F
Squarepoint Ops LLC	13F	Company	0.01%	11,553	$34,000	—	31 Mar 2020	13F

Institutional Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q2 2020

As of 30 Jun 2020, Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) was held by 78 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,848,899 shares. The largest 10 holders included BlackRock Inc., Consonance Capital Management LP, BVF INC/IL, VANGUARD GROUP INC, FMR LLC, STATE STREET CORP, AXA, Invesco Ltd., RENAISSANCE TECHNOLOGIES LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 78 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

Q2 2020 holders

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.